Fda approves Ajovy for migraine prevention in children and teens
The U.S. Food and Drug Administration has approved the single-dose Ajovy (fremanezumab-vfrm) injection for the preventive treatment of episodic migraine in children and adolescents.
Aug 11, 2025
0
16









